Month 2019
Vanadium-catalyzed Synthesis of Pyrazole-4-carboxylic Acids
ESI-MS (m/z): 358.0 [(M + H)+, 37Cl], 356.0 [(M + H)+,
35Cl]. Anal. Calcd. for C17H10ClN3O2S: C, 57.39; H,
2.83%. Found: C, 57.21; H, 2.93%.
3-(4-Chlorophenyl)-1-(6-methylbenzo[d]thiazol-2-yl)-1H-
[6] Bawn, C. E. H.; Jolley, J. Proc R Soc Lond A 1956, 237, 297.
[7] Brzaszcz, M.; Kloc, K.; Maposah, M.; Mlochowski, J. Synth
Commun 2000, 30, 4425.
[8] Chakraborty, D.; Gowda, R. R.; Malik, P. Tetrahedron Lett
2009, 50, 6553.
pyrazole-4-carboxylic acid 3o.
Obtained as white solid,
[9] Dalcanale, E.; Montanari, F. J Org Chem 1986, 51, 567.
[10] Graham, G. T.; Westheimer, F. J Am Chem Soc 1958, 80,
3030.
[11] Jeong, S. Y.; Kim, N.; Lee, J. C. Bull Korean Chem Soc 2014,
35, 3366.
yield 71%; mp 300–302°C. IR (υ cmꢀ1, KBr): 1704
(C═O str), 2666–2923 (OH str), 1605 (C═N str). 1H-
NMR (400 MHz, DMSO-d6):
δ
8.96 (s, 1H,
[12] Walling, C.; McElhill, E. A. J Am Chem Soc 1951, 73, 2927.
[13] Wiberg, K. B.; Stewart, R. J Am Chem Soc 1955, 77, 1786.
[14] Auwers, K. V.; Maub, H. Ber Dtsch Chem Ges 1926, 59, 611.
[15] Dains, F. B.; Long, W. S. J Am Chem Soc 1921, 43, 1200.
[16] Theodorou, V.; Paraskevopoulos, G.; Skobridis, K.
ARKIVOC 2015, vii, 101.
[17] Gokulan, P.; Jayakar, B. J Med Chem Drug Discov 2010, 1,
345.
[18] Gokulan, P. D.; Jayakar, B.; Alagarsamy, V.; Solomon, V. R.
Arzneimittelforschung 2012, 62, 457.
[19] Bruno, O.; Brullo, C.; Bondavalli, F.; Schenone, S.; Spisani,
S.; Falzarano, M. S.; Varani, K.; Barocelli, E.; Ballabeni, V.; Giorgio,
C.; Tognolini, M. Bioorg Med Chem 2009, 17, 3379.
[20] Cottineau, B.; Toto, P.; Marot, C.; Pipaud, A.; Chenault, J.
Bioorg Med Chem 2002, 12, 2105.
[21] Barrett, T. D.; Palomino, H. L.; Brondstetter, T. I.; Kanelakis,
K. C.; Wu, X.; Haug, P. V.; Yan, W.; Young, A.; Hua, H.; Hart, J. C.;
Tran, D. T.; Venkatesan, H.; Rosen, M. D.; Peltier, H. M.; Sepassi, K.;
Rizzolio, M. C.; Bembenek, S. D.; Mirzadegan, T.; Rabinowitz, M. H.;
Shankleyet, N. P. Mol Pharmacol 2011, 79, 910.
[22] Fukunari, A.; Okamoto, K.; Nishino, T.; Eger, B. T.; Pai, E.
F.; Kamezawa, M.; Yamada, I.; Katoet, N. J Pharmacol Exp Ther 2004,
311, 519.
[23] Rabinowitz, M. H.; Rosen, M. D.; Tarantino, K. T.;
Venkatesan, H. 4-Aminoquinazolin-2-yl-1-pyrazole-4-carboxylic acid
compounds as prolyl hydroxylase inhibitors. US Patent
US2014/8796263, May 8, 2014.
[24] Talukdar, D.; Sharma, K.; Bharadwaj, S. K.; Thakur, A. J
Synlett 2013, 24, 963.
pyrazole─H), 7.89 (d, J = 8.6 Hz, 2H, Ar─H), 7.80–7.82
(m, 2H, Ar─H), 7.48 (d, J = 8.6 Hz, 2H, Ar─H), 7.34
(dd, J = 8.6 and 1.2 Hz, 1H, Ar─H), 2.47 (s, 3H, CH3);
13C-NMR (100 MHz, CDCl3): δ 168.4, 158.3, 148.1,
133.1, 130.3, 128.5, 123.1, 122.0, 21.1. ESI-MS (m/z):
372.0 [(M + H)+, 37Cl], 370.0 [(M + H)+, 35Cl]. Anal.
Calcd. for C18H12ClN3O2S: C, 58.46; H, 3.27%. Found:
C, 58.57; H, 3.33%.
1-(Benzo[d]thiazol-2-yl)-3-(4-methoxyphenyl)-1H-pyrazole-
4-carboxylic acid 3p. Obtained as white solid, yield 80%;
mp 227–231°C. IR (υ cmꢀ1, KBr): 1694 (C═O str), 2578–
2959 (OH str), 1610 (C═N str). 1H-NMR (400 MHz,
DMSO-d6): δ 12.80 (bs, 1H, COOH), 8.97 (s, 1H,
pyrazole─H), 8.03 (d, J = 7.8 Hz, 1H, Ar─H), 7.93 (d,
J = 8.0 Hz, 1H, Ar─H), 7.85 (d, J = 8.8 Hz, 2H, Ar─H),
7.53 (t, J = 8.2 Hz, 1H, Ar─H), 7.43 (t, J = 8.0 Hz, 1H,
Ar─H), 7.05 (d, J = 8.8 Hz, 2H, Ar─H), 3.85 (s, 3H,
OCH3); 13C-NMR (100 MHz, CDCl3): δ 169.5, 160.9,
155.1, 150.7, 133.6, 133.0, 130.4, 126.9, 125.4, 123.3,
122.8, 122.7, 121.7, 114.2, 55.4. ESI-MS (m/z): 352.0
[M + H]+ (100%). Anal. Calcd. for C18H13N3O3S: C,
61.53; H, 3.73%. Found: C, 61.63; H, 3.83%.
[25] Zumbragel, N.; Sako, M.; Takizawa, S.; Sasai, H.; Groger, H.
Org Lett 2018, 20, 4723.
[26] Bratenko, M. K.; Chornous, V. A.; Vovk, M. V. Russ J Org
Chem 2001, 37, 552.
[27] Travis, B. R.; Sivakumar, M.; Hollist, G. O.; Borhan, B. Org
Lett 2013, 5, 1031.
[28] Sedelmeier, J.; Ley, S. V.; Baxendale, I. R.; Baumann, M. Org
Lett 2010, 12, 3618.
[29] Bala, R.; Kumari, P.; Sood, S.; Kumar, V.; Singh, N.; Singh,
[30] Sharma, P. K.; Singh, K.; Dhawan, S. N.; Singh, S. P. Indian J
Chem 2002, 41A, 2071.
[31] Singh, K.; Ralhan, S.; Sharma, P. K.; Dhawan, S. N. J Chem
Res 2005, 2005, 316.
Acknowledgments. The authors are grateful to Prof. H. S.
Dhaliwal, Vice-Chancellor, Eternal University, Baru Sahib, for
providing the necessary infrastructural facilities and financial
assistance. The authors would like to acknowledge RSIC,
Punjab University, Chandigarh, for recording the analytical data
during this study.
REFERENCES AND NOTES
[1] Weber, A.; Casini, A.; Heine, A.; Kuhn, D.; Supuran, C. T.;
Scozzafava, A.; Klebe, G. J Med Chem 2004, 47, 550.
[2] Gluszok, S.; Frédérick, R.; Foulon, C.; Klupsch, F.; Supuran,
C. T.; Vullo, D.; Scozzafava, A.; Goossens, J. F.; Masereel, B.; Depreux,
P.; Goossens, L. Bioorg Med Chem 2010, 18, 7392.
[32] Sharma, P. K.; Chandak, N.; Kumar, P.; Sharma, C.; Aneja, K.
R. Eur J Med Chem 2011, 46, 1425.
[3] Florent, T. R.; Meignan, S.; Foulon, C.; Six, P.; Gros, A.;
Mahieu, C. B.; Supuran, C. T.; Scozzafava, A.; Frédérick, R.; Masereel,
B.; Depreux, P.; Lansiaux, A.; Goossens, J. F.; Gluszok, S.; Goossens,
L. Bioorg Med Chem 2013, 21, 1451.
[4] Khloya, P.; Celik, G.; Ram, S.; Vullo, D.; Supuran, C. T.;
Sharma, P. K. Eur J Med Chem 2014, 76, 284.
SUPPORTING INFORMATION
Additional supporting information may be found online
in the Supporting Information section at the end of the
article.
[5] Abramovici, S.; Neumann, R.; Sasson, Y. J Mol Catal 1985,
29, 291.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet